Establishment Labs Holdings Inc. (ESTA) company profile
Close on Nov 18, 2026Market cap $2.11BP/E –Yield –
About Establishment Labs
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
The company is a global medical technology enterprise dedicated to patient safety and aesthetic outcomes within the breast aesthetics and reconstruction sectors. Its primary product line comprises Motiva Implants, silicone gel-filled breast implants that feature proprietary shell, barrier, and radio-frequency identification technologies. The portfolio includes five distinct families of Motiva Implants, the Flora Tissue Expander, and minimally invasive procedural technologies such as Preservé and Mia Femtech. The business distributes its offerings directly to physicians, hospitals, and clinics, as well as through specialized third-party medical device distributors.
Commercial operations extend across more than 100 countries globally through exclusive distribution partners alongside direct sales networks in the United States, Brazil, Argentina, and multiple European nations. Field sales and clinical outreach are supported by an internal sales organization of 278 staff members and contractors. Corporate operations are organized under a parent holding company established in the British Virgin Islands, following its initial incorporation in Costa Rica.
Summary of the business section of Establishment Labs's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Establishment Labs Holdings Inc.
- Founded
- 2004
- Headquarters
- Alajuela, G2
- Address
- Building B15 And 25 Coyol Free Zone 20101
- Phone
- 50624342400
- Website
- establishmentlabs.com
- Employees
- 1,004, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Incorporated in
- D8
- Fiscal year ends
- December 31
- Auditor
- CBIZ CPAs P.C., Los Angeles, California
Stock & identifiers
- Ticker
- ESTA
- Exchange
- Nasdaq
- IPO date
- Jul 20, 2018
- Shares outstanding
- 30M, Aug 6, 2026
- Public float
- $975.10M, Jun 30, 2025
- Filer category
- Large accelerated filer
- SEC CIK
- 1688757
- CUSIP
- G31249108
- FIGI
- BBG00L8R3CR6
- Share class FIGI
- BBG00L8R3DH5
- LEI
- 549300BCBQ714JNJ7V58
- EIN
- 98-1436377
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Filippo Caldini | Chief Executive Officer, Director | 48,829 |
| Cassandra Harris | Chief Financial Officer | 7,372 |
| Raj Denhoy | Chief Financial Officer | 23,348 |
| Edward J. Schutter | Director | 178,205 |
| Leslie Gillin | Director | 18,856 |
| Bryan Slotkin | Director | 33,052 |
| Ann Custin | Director | 24,626 |
| Nicholas Sheridan Lewin | Director | 1,099,439 |
| Quiros Juan Jose Chacon | Director | 984,012 |
| Taylor C. Harris | Director | 3,230 |
| Dennis E. Condon | Director | 9,385 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 Filippo Peter Caldini | $2.88M | $5.91M | $1.29M | $194 | $99 |
| FY2025 Juan Jose Chacon Quiros | $1.65M | $7.01M | $1.29M | $194 | $99 |
| FY2024 | $2.60M | $7.27M | $1.14M | $167 | $105 |
| FY2023 | $2.42M | $304.12K | $982.65K | $94 | $106 |
| FY2022 | $2.58M | $5.60M | $1.43M | $237 | $100 |
| FY2021 | $2.28M | $5.86M | $3.38M | $244 | $125 |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Option awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|---|
| Filippo "Peter" Caldini Chief Executive Officer | $528.75K | $849.95K | $851.55K | $622.80K | $28.98K | $2.88M | +135% |
| Juan José Chacón Quirós Former Chief Executive Officer | $218.92K | – | – | – | $1.44M | $1.65M | -36% |
| Rajbir S. Denhoy Former Chief Financial Officer | $370.00K | $389.98K | $390.77K | $200.93K | $74.59K | $1.43M | +27% |
| S. Ross Mansbach General Counsel and Chief Compliance Officer | $352.04K | $276.89K | $277.44K | $190.21K | $53.33K | $1.15M | +8% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Jul 20, 2018
- Offer price
- $18.00
- Securities offered
- 3,715,277
- Gross proceeds
- $66.87M
- Exchange
- Nasdaq
- First trading day
- Jul 19, 2018
- First-day close
- $24.75+37.5%
- Lock-up ends (est.)
- Jan 15, 2019
“The initial public offering price is $18.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of December 31, 2025, we had 1,004 employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| May 22, 2025 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Mar 1, 2024 | Late filing | Notification of late filing |
| Jul 20, 2018 | IPO | Initial public offering priced (424B4 prospectus) |
| Jul 16, 2018 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?